Urocortin and corticotropin-releasing factor receptor 2 in human renal cell carcinoma: Disruption of an endogenous inhibitor of angiogenesis and proliferation

World Journal of Urology

Volumn 27, Issue 6, 2009, Pages 825-830

  Tezval, Hossein ^a   Jurk, Stefanie ^a   Atschekzei, Farahnaz ^a   Becker, Jan U ^a   Jahn, Olaf ^b   Serth, Jürgen ^a   Kuczyk, Markus A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Angiogenesis; CRFR2; Kidney tumor; Proliferation; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 2; MESSENGER RNA; UROCORTIN;

ADULT; ARTICLE; CELL DIVISION; CELL NUCLEUS; EPITHELIUM CELL; GENETICS; HUMAN; IN VITRO STUDY; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ADULT; CARCINOMA, RENAL CELL; CELL DIVISION; CELL NUCLEUS; EPITHELIAL CELLS; HUMANS; KIDNEY; KIDNEY NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; UROCORTINS;

EID: 71249092636     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-009-0417-x     Document Type: Article

References (24)

1. F Arcuri M Cintorino P Florio F Floccari L Pergola R Romagnoli F Petraglia P Tosi M Teresa Del Vecchio 2002 Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma Prostate 52 167 172 10.1002/pros.10094 (Pubitemid 34791219)
2. TL Bale FJ Giordano RP Hickey Y Huang AK Nath KL Peterson WW Vale KF Lee 2002 Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularization Proc Natl Acad Sci USA 99 7734 7739 10.1073/pnas.102187099 (Pubitemid 34568760)
3. E Chatzaki M Lambropoulou TC Constantinidis N Papadopoulos Y Tache G Minopoulos DE Grigoriadis 2006 Corticotropin-releasing factor (CRF) receptor type 2 in the human stomach: protective biological role by inhibition of apoptosis J Cell Physiol 209 905 911 10.1002/jcp.20792 (Pubitemid 44665712)
4. CJ Donaldson SW Sutton MH Perrin AZ Corrigan KA Lewis JE Rivier JM Vaughan WW Vale 1996 Cloning and characterization of human urocortin Endocrinology 137 2167 2170 10.1210/en.137.5.2167 (Pubitemid 26139701)
5. P Florio G De Falco E Leucci M Torricelli PB Torres P Toti A Dell'Anna E Tiso R Santopietro L Leoncini F Petraglia 2006 Urocortin expression is downregulated in human endometrial carcinoma J Endocrinol 190 99 105 10.1677/joe.1.06726 (Pubitemid 44161065)
6. M Gama-Carvalho M Carmo-Fonseca 2001 The rules and roles of nucleocytoplasmic shuttling proteins FEBS Lett 498 157 163 10.1016/S0014- 5793(01)02487-5 (Pubitemid 32539194)
7. Z Hao Y Huang J Cleman IS Jovin WW Vale TL Bale FJ Giordano 2008 Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation Proc Natl Acad Sci USA 105 3939 3944 10.1073/pnas.0712366105 (Pubitemid 351723503)
8. MC Hu DF Lee W Xia LS Golfman F Ou-Yang JY Yang Y Zou S Bao N Hanada H Saso R Kobayashi MC Hung 2004 IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a Cell 117 225 237 10.1016/S0092-8674(04)00302-2 (Pubitemid 38496242)
9. O Jahn J Radulovic O Stiedl H Tezval K Eckart J Spiess 2005 Corticotropin-releasing factor binding protein-a ligand trap? Mini Rev Med Chem 5 953 960 10.2174/138955705774329500 (Pubitemid 41300741)
10. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 43 66 10.3322/canjclin.57.1.43
11. SJ Mandriota KJ Turner DR Davies PG Murray NV Morgan HM Sowter CC Wykoff ER Maher AL Harris PJ Ratcliffe PH Maxwell 2002 HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron Cancer Cell 1 459 468 10.1016/S1535-6108(02)00071-5 (Pubitemid 41039126)
12. SK Mishra PA Keyel MJ Hawryluk NR Agostinelli SC Watkins LM Traub 2002 Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor EMBO J 21 4915 4926 10.1093/emboj/cdf487
13. EJ Nouwen WA Verstrepen N Buyssens MQ Zhu ME De Broe 1994 Hyperplasia, hypertrophy, and phenotypic alterations in the distal nephron after acute proximal tubular injury in the rat Lab Invest 70 479 493
14. IK Poon DA Jans 2005 Regulation of nuclear transport: central role in development and transformation? Traffic 6 173 186 10.1111/j.1600-0854.2005. 00268.x (Pubitemid 40298152)
15. AK Raap MP van de Corput RA Vervenne RP van Gijlswijk HJ Tanke J Wiegant 1995 Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides Hum Mol Genet 4 529 534 10.1093/hmg/4.4.529
16. TA Skolarus MF Serrano DA Berger TL Bullock Y Yan PA Humphrey AS Kibel 2008 The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification J Urol 179 439 443 10.1016/j.juro.2007.09.076 (Discussion pp 443-434)
17. H Tezval S Jurk F Atschekzei J Serth MA Kuczyk AS Merseburger 2009 The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways Prostate 69 443 448 10.1002/pros.20892
18. H Tezval AS Merseburger I Matuschek S Machtens MA Kuczyk J Serth 2008 RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma BMC Urol 8 12 10.1186/1471-2490-8-12
19. J Vaughan C Donaldson J Bittencourt MH Perrin K Lewis S Sutton R Chan AV Turnbull D Lovejoy C Rivier, et al. 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 378 287 292 10.1038/378287a0
20. J Wang S Li 2007 Corticotropin-releasing factor family and its receptors: tumor therapeutic targets? Biochem Biophys Res Commun 362 785 788 10.1016/j.bbrc.2007.08.014
21. J Wang Y Xu Y Xu H Zhu R Zhang G Zhang S Li 2008 Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2 Cancer Invest 26 359 368 10.1080/07357900701788106 (Pubitemid 351601386)
22. SC Wang MC Hung 2005 Cytoplasmic/nuclear shuttling and tumor progression Ann N Y Acad Sci 1059 11 15 10.1196/annals.1339.002 (Pubitemid 43211605)
23. W Xie L Li SN Cohen 1998 Cell cycle-dependent subcellular localization of the TSG101 protein and mitotic and nuclear abnormalities associated with TSG101 deficiency Proc Natl Acad Sci USA 95 1595 1600 10.1073/pnas.95.4.1595 (Pubitemid 28103438)
24. Q Zhong Y Chen D Jones WH Lee 1998 Perturbation of TSG101 protein affects cell cycle progression Cancer Res 58 2699 2702